Global Blood Plasma Market Expected To Register 9.9% CAGR During The Forecast Period

As per the researchers at Zion Market Research, the valuation of the global blood plasma market is anticipated to be around USD 49.96 million by 2025, from about USD 28.01 million in 2018, expanding at about 9.9% CAGR during the forecast period. Few of the key players active in the global blood plasma market consist of Medivators Inc. (Cantel Medical Corp.), Olympus Corporation, STERIS Plc., Getinge Group, Steelco S.P.A, Belimed AG (Metall Zug), F. Hoffmann-La Roche Ltd, Pfizer Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Merck & Co., Inc., Bayer AG, Abbott Laboratories, Dickinson and Company, Alere Inc., Cantel Medical Corp., Bemis Company, Crosstex International, Inc., Covidien plc, Diversey, Inc, Danaher Corp., MMM Group, Getinge Group, Sealed Air Corp, Purdue Pharma LP, Synergy Health plc, and Semperit AG Holding. The market for blood plasma is extremely fragmented and the prominent players implement several approaches like expansions, new product launches, joint ventures, agreements, acquisitions, partnerships, and others to strengthen their footprints within this global market. To cite, the Cobas plasma separation card was launched by Roche in 2018. This new solution is an easy-to-use and stable sample gathering tool for HIV plasma viral load testing.

Rising Incidence Of Life-Threatening Disorders To Drive The Global Market Growth

The expansion of the global blood plasma market is primarily propelled by the rise in the incidence of severe disorders, particularly hemophilia. Furthermore, the increase in the use of blood plasma derivatives products, the rise in elderly population around the globe, and the rise in alertness about blood & plasma donation are few other factors anticipated to drive the global market growth. Nevertheless, the elevated price of plasma derivative-based therapy along with the post-operative perils related to plasma replacement therapy might obstruct the growth of the market. On the other hand, the development of improved techniques for preservation of blood plasma together with sophisticated processes for fractionation and likely prospective in untapped markets in the budding regions are anticipated to offer lucrative growth avenues for the market in the coming period.

By Application, Hemorrhage Segment Expected To Lead The Global Market

Hemorrhage is accountable for about 30–40% of the trauma-associated mortality. The rise in the use of blood plasma while treating hemorrhage is expected to propel the segmental growth during the forecast period. As per the Brain Aneurysm Foundation, about 6 million individuals in the US have an unruptured brain aneurysm and need immense plasma transfusion to put off further injuries. In addition, the rise in the implementation of platelets and plasma together with RBCs (red blood cells) to reduce the impacts of hemorrhage is also projected to drive the segmental expansion.

Asia Pacific To Witness Substantial Growth In Market During The Forecast Period

In 2018, the highest share in the global blood plasma market was held by North America and trailed by Europe. However, Asia Pacific is projected to lead the global market during the forecast period, on account of the higher population base, rise in patient alertness along with the rise in disposable income. In addition, Asia is a huge continent and has surfaced as a center of life-threatening diseases.

Browse the full “Global Blood Plasma Market - By Distribution Channel (Ambulatory Surgical Centers, Hospitals, And Others), By Application (Coagulation Factor Deficiencies, Hemorrhage, Thrombotic Thrombocytopenic Purpura, Liver Disease, And Other Plasma Applications), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025.” Report at https://www.zionmarketresearch.com/report/blood-plasma-market

The global blood plasma market is segmented as follows:

By Application

• Coagulation factor deficiencies
• Thrombotic thrombocytopenic purpura
• Hemorrhage
• Liver disease
• Other plasma applications

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region   

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com